TB-500 talk online is full of loading weeks, maintenance weeks, and fixed calendars. Published research on thymosin β4 / TB-500–related work does not give the public a clean, one-size human timing chart the way forums do. What TB-500 is (plain English) TB-500 is commonly discussed as a synthetic fragment related to thymosin β4, a peptide studied for roles in cell migration, actin dynamics, and tissue-repair pathways. A lot of the “how often / how long” chatter online is community protocol culture, not a single definitive human schedule from large trials. Evidence context (label honestly) • Preclinical / mechanistic — stronger share of the literature (animal and cell work on thymosin β4 pathways) • Human — limited / early relative to how confident many schedule charts sound • Anecdotal / community — where most “load then maintain” calendars live Important limitation A detailed forum timing chart is not the same thing as a published research protocol in a defined population. Mixing those layers is how people get overconfident about frequency and duration. What “timing” conversations should actually weigh 1. What layer of evidence you’re looking at (human vs preclinical vs anecdote) 2. Whether the claim is about mechanism or about a specific calendar 3. That research use and internet “protocols” are different languages — don’t collapse them HARD boundary for this classroom: no personalized medical dosing advice. We’re teaching how to read claims, not writing your schedule. Practical educational takeaway When someone posts a TB-500 “loading phase,” ask: Is this from a published protocol in a defined study, or from community practice? Weight those differently. Question for the community: When you evaluate TB-500 timing claims, do you start with published study design — or with community schedule charts — and why?

A purity percentage without a test date is incomplete evidence. Here’s the literacy point in plain English: A Certificate of Analysis is a snapshot of one sample, from one lab run, at one moment in time. The date on that report tells you when that snapshot was taken — not when your vial was filled, shipped, or stored. What a test date helps you check • Whether the report is recent enough to be useful as a batch claim • Whether the vendor is recycling the same PDF across months of marketing • Whether you’re looking at a current lot story or a stale screenshot What a test date does NOT prove • That your vial was the sample tested • That identity was confirmed (that’s usually a separate method, often MS) • That quantity/peptide content matches the label • That nothing changed after the test (storage, handling, underfill) Evidence label: this is QC / documentation literacy, not clinical evidence. A dated COA is still only as strong as lot match + methods + lab credibility. Common misconception: “If it says 99% and looks official, the date doesn’t matter.” Reality: an undated or ancient report makes the rest of the claims harder to trust — not automatically fake, just incomplete. Practical takeaway When you open a COA, hunt for test date + lot/batch ID + purity method + identity method. Missing date = ask for a current report tied to the lot on your vial before you treat the PDF as proof. Question for the community: Have you seen vendors reuse the same COA PDF for months — and if so, what did you ask for next?